The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Observed survival benefit with limited exposure of durvalumab in unresectable stage III non-small cell lung cancer at a large community-based institution.
 
Deepak Vadehra
No Relationships to Disclose
 
Christopher R Pallas
No Relationships to Disclose
 
Donald Moore
Consulting or Advisory Role - Oncopeptides
 
Jeryl Jean Villadolid
Employment - Bristol-Myers Squibb; Merck
Stock and Other Ownership Interests - TG Therapeutics
Consulting or Advisory Role - AstraZeneca
Speakers' Bureau - Merck
Travel, Accommodations, Expenses - Merck
 
Myra M. Robinson
No Relationships to Disclose
 
Kathryn Finch Mileham
Honoraria - Bristol-Myers Squibb; Takeda
Consulting or Advisory Role - AstraZeneca; Bayer
Speakers' Bureau - Merck
Research Funding - Celgene
 
Daniel R. Carrizosa
Consulting or Advisory Role - Curio Science
Speakers' Bureau - Research to Practice
Research Funding - Aeglea Biotherapeutics (Inst); Celgene (Inst); Coordination Pharmaceuticals (Inst); GlaxoSmithKline (Inst); Loxo (Inst); Merck (Inst); Pfizer (Inst); Takeda (Inst)